Latest filing published 01 Sept 2026 for Crinetics Pharmaceuticals, Inc., €8.5M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Wendell Wierenga span 3 companies, the busiest being Cytokinetics Inc, Dermata Therapeutics, Inc. and Crinetics Pharmaceuticals, Inc. Over a trading history stretching from 17 August 2021 to 1 September 2026, the count stands at 14 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 1 September 2026 came the latest disclosure, a transaction for €8.5M in Crinetics Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations